<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Alzheimer's Disease Prediction Using EffNetViTLoRA and BiLSTM with Multimodal Longitudinal MRI Data - Health AI Hub</title>
    <meta name="description" content="This paper introduces a novel, end-to-end hybrid deep learning model, EffNetViTLoRA integrated with BiLSTM, designed for early Alzheimer's Disease prediction us">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Alzheimer's Disease Prediction Using EffNetViTLoRA and BiLSTM with Multimodal Longitudinal MRI Data</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.22774v1" target="_blank">2511.22774v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-27
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Mahdieh Behjat Khatooni, Mohsen Soryani
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.22774v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.22774v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a novel, end-to-end hybrid deep learning model, EffNetViTLoRA integrated with BiLSTM, designed for early Alzheimer's Disease prediction using multimodal longitudinal MRI data. The model effectively captures both spatial and temporal features, achieving a state-of-the-art average accuracy of 95.05% in distinguishing progressive Mild Cognitive Impairment (pMCI) from stable MCI (sMCI) by predicting cognitive status at 48 months.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Early and accurate prediction of Alzheimer's disease progression, particularly differentiating sMCI from pMCI, is paramount for timely clinical intervention, personalized patient management strategies, and optimizing the efficacy of emerging therapeutic approaches.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI model (a hybrid of Convolutional Neural Networks, Vision Transformers, and BiLSTM) is applied to multimodal longitudinal MRI data and non-image biomarkers to predict the progression of Mild Cognitive Impairment (MCI) to Alzheimer's disease. This serves as an advanced diagnostic and prognostic tool for the early detection of AD, enabling earlier clinical intervention and personalized patient management.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>The study addresses the critical challenge of early Alzheimer's disease (AD) prediction, specifically focusing on classifying individuals with Mild Cognitive Impairment (MCI) into stable (sMCI) or progressive (pMCI) categories.</li>
                    
                    <li>A generalized, end-to-end deep learning model is proposed, utilizing multimodal longitudinal data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), including four consecutive MRI timepoints and non-image biomarkers.</li>
                    
                    <li>The core architecture, EffNetViTLoRA, integrates Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs) to effectively extract both local spatial features and global contextual dependencies from MRI scans.</li>
                    
                    <li>Bidirectional Long Short-Term Memory (BiLSTM) networks are employed to process the sequence of extracted spatial features across four timepoints, combined with non-image biomarkers, to model temporal progression and predict cognitive status at month 48.</li>
                    
                    <li>The multimodal model achieved a high average progression prediction accuracy of 95.05% for the sMCI vs. pMCI classification.</li>
                    
                    <li>The model demonstrates state-of-the-art performance, outperforming existing studies in longitudinal AD prediction, highlighting the efficacy of its integrated spatial and temporal modeling approach.</li>
                    
                    <li>This work underscores the importance of combining advanced spatial feature extraction techniques with temporal modeling for robust early detection of Alzheimer's disease.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employs a generalized, end-to-end deep learning architecture combining a hybrid EffNetViTLoRA model (integrating CNNs and Vision Transformers for spatial feature extraction from MRI scans) with Bidirectional Long Short-Term Memory (BiLSTM) networks. The BiLSTM processes the sequence of spatial features extracted from four consecutive MRI timepoints, along with non-image biomarkers, to model temporal progression and predict each subject's cognitive status (sMCI or pMCI) at month 48.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The proposed multimodal deep learning model achieved an impressive average progression prediction accuracy of 95.05% in classifying individuals as sMCI or pMCI. This performance significantly surpasses existing studies in longitudinal AD prediction, underscoring the superior effectiveness of combining advanced spatial feature learning from MRI (using EffNetViTLoRA) with robust temporal modeling of longitudinal and multimodal data (using BiLSTM).</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This model holds significant clinical potential for improving the precision and timeliness of AD diagnosis. It could enable earlier and more accurate stratification of MCI patients, allowing clinicians to identify individuals at high risk of progressing to AD (pMCI) for targeted early interventions, personalized disease management, and more effective selection for clinical trials, potentially delaying disease onset or mitigating its severity.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the study.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state any future research directions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Radiology</span>
                    
                    <span class="tag">Geriatrics</span>
                    
                    <span class="tag">Cognitive Neuroscience</span>
                    
                    <span class="tag">Diagnostic Imaging</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Alzheimer's Disease</span>
                    
                    <span class="tag tag-keyword">Mild Cognitive Impairment</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">MRI</span>
                    
                    <span class="tag tag-keyword">Longitudinal Data</span>
                    
                    <span class="tag tag-keyword">BiLSTM</span>
                    
                    <span class="tag tag-keyword">Vision Transformers</span>
                    
                    <span class="tag tag-keyword">Early Prediction</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Alzheimer's disease (AD) is a prevalent neurodegenerative disorder that progressively impairs memory, decision-making, and overall cognitive function. As AD is irreversible, early prediction is critical for timely intervention and management. Mild Cognitive Impairment (MCI), a transitional stage between cognitively normal (CN) aging and AD, plays a significant role in early AD diagnosis. However, predicting MCI progression remains a significant challenge, as not all individuals with MCI convert to AD. MCI subjects are categorized into stable MCI (sMCI) and progressive MCI (pMCI) based on conversion status. In this study, we propose a generalized, end-to-end deep learning model for AD prediction using MCI cases from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Our hybrid architecture integrates Convolutional Neural Networks and Vision Transformers to capture both local spatial features and global contextual dependencies from Magnetic Resonance Imaging (MRI) scans. To incorporate temporal progression, we further employ Bidirectional Long Short-Term Memory (BiLSTM) networks to process features extracted from four consecutive MRI timepoints along with some other non-image biomarkers, predicting each subject's cognitive status at month 48. Our multimodal model achieved an average progression prediction accuracy of 95.05\% between sMCI and pMCI, outperforming existing studies in AD prediction. This work demonstrates state-of-the-art performance in longitudinal AD prediction and highlights the effectiveness of combining spatial and temporal modeling for the early detection of Alzheimer's disease.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>